|
G |
Abcc4 |
ATP-binding cassette, sub-family C member 4 |
multiple interactions |
ISO |
Mefloquine inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16004972 |
|
NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C member 5 |
increases export multiple interactions |
ISO |
ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein daidzein inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; hesperetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Quercetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Silymarin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16156793 |
|
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
affects transport multiple interactions increases export increases transport |
ISO |
ABCC2 protein affects the transport of 5(6)-carboxy-2',7'-dichlorofluorescein 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]; Ascorbic Acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Benzbromarone inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Calcium deficiency inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; cyanoginosin LR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin RR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin-LF inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Probenecid inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Tobacco Smoke Pollution inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog] ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog [ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 gene mutant form inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:19326901 PMID:21240898 PMID:21341280 PMID:23562342 PMID:24907646 PMID:24909372 PMID:24973091 PMID:25862123 PMID:27450509 PMID:31348918 More...
|
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
multiple interactions increases transport |
ISO |
[ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein Benzbromarone inhibits the reaction [ABCC3 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:24907646 PMID:31348918 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C member 5 |
multiple interactions increases uptake increases transport |
ISO |
Benzbromarone inhibits the reaction [ABCC5 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] ABCC5 protein results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein |
CTD |
PMID:31348918 PMID:35066093 |
|
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
|
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
multiple interactions increases transport |
ISO |
quercetin 3'-sulfate inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] |
CTD |
PMID:21244849 |
|
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
multiple interactions |
ISO |
ABCC2 protein affects the transport of [5-chloromethylfluorescein co-treated with Glutathione] |
CTD |
PMID:16049127 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
increases export |
ISO |
ABCC1 protein results in increased export of 6-carboxyfluorescein |
CTD |
PMID:17940500 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
affects export multiple interactions |
ISO |
ABCC2 protein affects the export of 6-carboxyfluorescein Probenecid inhibits the reaction [ABCC2 protein affects the export of 6-carboxyfluorescein] |
CTD |
PMID:11477083 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
increases import increases uptake multiple interactions |
ISO |
SLC22A6 protein results in increased import of 6-carboxyfluorescein SLC22A6 protein results in increased uptake of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Unithiol analog inhibits the reaction [SLC22A6 protein results in increased uptake of 6-carboxyfluorescein] |
CTD |
PMID:20237588 PMID:28629854 |
|
NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
increases import increases uptake multiple interactions |
ISO |
SLC22A8 protein results in increased import of 6-carboxyfluorescein SLC22A8 protein results in increased uptake of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Cadmium Chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; lead chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; sodium arsenate promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Unithiol analog inhibits the reaction [SLC22A8 protein results in increased uptake of 6-carboxyfluorescein] |
CTD |
PMID:20237588 PMID:28629854 |
|
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions decreases expression |
ISO EXP |
[mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein; diphenyleneiodonium promotes the reaction [mangostin results in decreased expression of ACTA2 protein]; mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein] mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30502394 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
affects localization |
ISO |
mangostin affects the localization of AIFM1 protein |
CTD |
PMID:24480042 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases phosphorylation multiple interactions |
ISO |
mangostin results in decreased phosphorylation of AKT1 protein [mangostin co-treated with MK 2206] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:23954321 PMID:30502394 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
ISO |
mangostin results in increased expression of BAX protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
ISO |
mangostin results in decreased expression of BCL2 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
mangostin results in decreased expression of BID protein |
CTD |
PMID:24480042 |
|
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein] |
CTD |
PMID:26357513 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] |
CTD |
PMID:24480042 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
mangostin results in increased activity of CASP8 protein |
CTD |
PMID:24480042 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
mangostin results in increased activity of CASP9 protein |
CTD |
PMID:23954321 PMID:24480042 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
mangostin results in increased expression of CYCS protein |
CTD |
PMID:24480042 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions decreases expression affects response to substance |
ISO |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] mangostin results in decreased expression of ESR1 protein ESR1 protein affects the susceptibility to mangostin |
CTD |
PMID:24480042 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
EXP |
mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein] |
CTD |
PMID:30502394 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Hdac1 |
histone deacetylase 1 |
increases expression |
ISO |
mangostin results in increased expression of HDAC1 protein |
CTD |
PMID:30502394 |
|
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions decreases secretion |
ISO EXP |
diphenyleneiodonium promotes the reaction [mangostin results in decreased secretion of HMGB1 protein]; mangostin affects the localization of and results in decreased acetylation of HMGB1 protein; mangostin promotes the reaction [diphenyleneiodonium results in decreased secretion of HMGB1 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:28722351 |
|
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
|
|
G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:28722351 |
|
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
|
|
G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K4 protein |
CTD |
PMID:28722351 |
|
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK1 protein mangostin analog results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK3 protein mangostin analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:28722351 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:28722351 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein] mangostin analog results in decreased expression of MMP2 mRNA; mangostin analog results in decreased expression of MMP2 protein |
CTD |
PMID:28722351 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein] mangostin analog results in decreased expression of MMP9 mRNA; mangostin analog results in decreased expression of MMP9 protein |
CTD |
PMID:28722351 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
mangostin results in increased cleavage of PARP1 protein |
CTD |
PMID:23954321 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] |
CTD |
PMID:18424012 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Sirt3 |
sirtuin 3 |
multiple interactions increases expression |
ISO EXP |
SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] [mangostin co-treated with Carbon Tetrachloride] results in increased expression of and results in increased secretion of SIRT3 protein mangostin results in increased expression of SIRT3 protein |
CTD |
PMID:30502394 |
|
NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
|
|
G |
Tff1 |
trefoil factor 1 |
decreases expression |
ISO |
mangostin results in decreased expression of TFF1 protein |
CTD |
PMID:24480042 |
|
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:18424012 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression multiple interactions |
ISO |
mangostin results in increased expression of TP53 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TP53 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
|
G |
Adam17 |
a disintegrin and metallopeptidase domain 17 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of ADAM17 mRNA] |
CTD |
PMID:37528096 |
|
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of AKT1 mRNA]; bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36518482 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Brd4 |
bromodomain containing 4 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 protein] |
CTD |
PMID:37528096 |
|
NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein] |
CTD |
PMID:37127800 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
bellidifolin results in increased expression of CASP3 protein |
CTD |
PMID:33299414 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
bellidifolin results in increased expression of CASP8 protein |
CTD |
PMID:33299414 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
bellidifolin results in decreased expression of CEBPB mRNA |
CTD |
PMID:33299414 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Gck |
glucokinase |
decreases activity |
EXP |
bellidifolin results in decreased activity of GCK protein |
CTD |
PMID:19962285 |
|
NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
bellidifolin results in increased expression of GCLC mRNA; bellidifolin results in increased expression of GCLC protein |
CTD |
PMID:30800665 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein] |
CTD |
PMID:37127800 |
|
NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of GSK3B mRNA]; bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of GSK3B protein] |
CTD |
PMID:36518482 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
bellidifolin results in increased expression of HMOX1 mRNA; bellidifolin results in increased expression of HMOX1 protein |
CTD |
PMID:30800665 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein] |
CTD |
PMID:37127800 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein] |
CTD |
PMID:37127800 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Insr |
insulin receptor |
increases expression |
EXP |
bellidifolin results in increased expression of INSR |
CTD |
PMID:19962285 |
|
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
|
|
G |
Irs1 |
insulin receptor substrate 1 |
increases expression |
EXP |
bellidifolin results in increased expression of IRS1 |
CTD |
PMID:19962285 |
|
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
|
|
G |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of MYH7 protein] |
CTD |
PMID:37528096 |
|
NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein] |
CTD |
PMID:37127800 |
|
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 protein] |
CTD |
PMID:37528096 |
|
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
|
|
G |
Nppa |
natriuretic peptide type A |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPA protein] |
CTD |
PMID:37528096 |
|
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
|
|
G |
Nppb |
natriuretic peptide type B |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] |
CTD |
PMID:37528096 |
|
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of and affects the localization of NR4A1 protein] |
CTD |
PMID:33995055 |
|
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PARP1 protein |
CTD |
PMID:33299414 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Ptger2 |
prostaglandin E receptor 2 (subtype EP2) |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGER2 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
|
|
G |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGER4 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGS2 protein |
CTD |
PMID:33299414 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein] |
CTD |
PMID:37127800 |
|
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:33995055 |
|
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:33995055 PMID:35586685 |
|
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein] |
CTD |
PMID:33995055 |
|
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
|
|
G |
Sox9 |
SRY (sex determining region Y)-box 9 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of SOX9 protein] bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SOX9 protein] |
CTD |
PMID:35586685 |
|
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases expression |
ISO |
bellidifolin results in decreased expression of and results in decreased phosphorylation of STAT3 protein bellidifolin results in decreased expression of STAT3 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of SMAD2 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR1 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR2 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of and affects the localization of NR4A1 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SOX9 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:33995055 PMID:35586685 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor I |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR1 protein] |
CTD |
PMID:33995055 |
|
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor II |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR2 protein] |
CTD |
PMID:33995055 |
|
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA] |
CTD |
PMID:37528096 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions increases secretion increases export |
ISO EXP |
[carvedilol results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; [Verapamil results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; desisobutyrylciclesonide inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Ketoconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Mometasone Furoate inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of fluorexon] Amiodarone inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Clotrimazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Ketoconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] |
CTD |
PMID:10571255 PMID:12235267 PMID:16442095 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
affects export increases export increases import affects transport multiple interactions |
ISO EXP |
ABCC1 protein affects the export of fluorexon ABCC1 protein results in increased export of fluorexon ABCC1 protein results in increased import of fluorexon ABCC1 protein affects the transport of fluorexon [Glycyrrhetinic Acid affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [Indomethacin affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [matairesinol affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [verlukast affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; Mefloquine inhibits the reaction [ABCC1 protein affects the export of fluorexon]; nobiletin promotes the reaction [ABCC1 protein results in increased import of fluorexon]; Quercetin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; robinetin inhibits the reaction [ABCC1 protein affects the export of fluorexon]; Silymarin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon] |
CTD |
PMID:10685512 PMID:15670588 PMID:16004972 PMID:16156793 PMID:18204840 PMID:18955043 PMID:26454883 More...
|
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
affects export increases abundance multiple interactions affects transport |
ISO |
ABCC2 protein affects the export of fluorexon ABCC2 protein alternative form results in increased abundance of fluorexon robinetin inhibits the reaction [ABCC2 protein affects the export of fluorexon] ABCC2 protein affects the transport of fluorexon |
CTD |
PMID:15670588 PMID:15848949 PMID:22027652 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcc6 |
ATP-binding cassette, sub-family C member 6 |
affects transport |
ISO |
ABCC6 affects the transport of fluorexon |
CTD |
PMID:14667841 |
|
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
|
|
|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
affects export multiple interactions |
EXP |
ABCB11 protein affects the export of calcein AM ditekiren inhibits the reaction [ABCB11 protein affects the export of calcein AM] |
CTD |
PMID:10617675 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases transport increases export multiple interactions increases activity affects export increases secretion |
ISO |
ABCB1 protein results in increased transport of calcein AM ABCB1 protein results in increased export of calcein AM ABCB1A protein promotes the reaction [Emodin results in increased export of calcein AM] 2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Endosulfan co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [phosalone co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [pinostrobin results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [tectochrysin results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [Verapamil binds to and results in decreased activity of ABCB1 protein] inhibits the reaction [sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]]; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; ABCB1 protein affects the reaction [Mifepristone results in decreased transport of calcein AM]; ABCB1 protein affects the reaction [zosuquidar trihydrochloride results in decreased transport of calcein AM]; Atorvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; chlorpyrifos-methyl affects the reaction [ABCB1 protein results in increased transport of calcein AM]; Cyclosporine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; deoxynivalenol inhibits the reaction [valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]]; Diazinon inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Diazinon promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Endosulfan inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; fenoxycarb inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; phosalone inhibits the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; propiconazole inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Simvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Verapamil promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]] calcein AM results in increased activity of ABCB1 protein mutant form |
CTD |
PMID:10617675 PMID:12711602 PMID:15616150 PMID:16121039 PMID:19223659 PMID:19549930 PMID:21321059 PMID:21783720 PMID:29174985 PMID:30217652 PMID:37259354 More...
|
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
increases transport multiple interactions |
ISO |
ABCC1 protein results in increased transport of calcein AM [ABCC1 protein results in increased susceptibility to Silver Nitrate] which results in decreased export of calcein AM; [ABCC1 protein results in increased susceptibility to Silver] which results in decreased export of calcein AM; [MLN 8237 results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; [MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; verlukast inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; zearalenol metabolite inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC1 protein results in increased transport of calcein AM] |
CTD |
PMID:19239227 PMID:19647055 PMID:27376922 PMID:34896433 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
affects transport multiple interactions increases transport increases export |
ISO |
ABCC2 protein affects the transport of calcein AM Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM; Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; montelukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15616150 PMID:19239227 PMID:19647055 PMID:19952419 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
affects transport multiple interactions increases transport |
ISO |
ABCC3 protein affects the transport of calcein AM Dexamethasone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Glutathione promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Hydrocortisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Prednisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC3 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15979871 PMID:19647055 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcc4 |
ATP-binding cassette, sub-family C member 4 |
multiple interactions |
ISO |
Glutathione promotes the reaction [ABCC4 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
|
|
G |
Abcc6 |
ATP-binding cassette, sub-family C member 6 |
multiple interactions |
ISO |
Glutathione promotes the reaction [ABCC6 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
|
|
G |
Myc |
myelocytomatosis oncogene |
multiple interactions |
ISO |
[MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM |
CTD |
PMID:19239227 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
decreases activity |
ISO |
Cannabinol results in decreased activity of ABCC1 protein |
CTD |
PMID:18619955 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
affects binding |
ISO |
Cannabinol binds to CNR1 protein |
CTD |
PMID:19679411 |
|
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
multiple interactions increases metabolic processing |
ISO |
Cannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CYP2J2 protein results in increased metabolism of Cannabinol |
CTD |
PMID:29689453 |
|
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of FOS protein |
CTD |
PMID:10670588 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Rimonabant inhibits the reaction [Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
CTD |
PMID:11520904 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 mRNA]; Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein]; Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]; KN 93 inhibits the reaction [Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]] |
CTD |
PMID:8662742 PMID:10670588 PMID:11809870 |
|
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of JUN protein |
CTD |
PMID:10670588 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein] |
CTD |
PMID:31154070 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:19910459 |
|
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions increases activity |
ISO |
[Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium |
CTD |
PMID:31096838 |
|
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
multiple interactions |
ISO |
Cannabinol binds to and results in increased activity of TRPV2 protein |
CTD |
PMID:18550765 |
|
NCBI chr11:62,465,312...62,491,131
Ensembl chr11:62,465,312...62,491,341
|
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNB1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased expression of IRF3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the phosphorylation of and affects the expression of and affects the localization of JUN protein] |
CTD |
PMID:31350693 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein] |
CTD |
PMID:31350693 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:31350693 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TICAM1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr17:56,576,462...56,583,767
Ensembl chr17:56,576,319...56,583,786
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:31350693 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] |
CTD |
PMID:34655103 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased secretion of MUC5AC protein] |
CTD |
PMID:34655103 |
|
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
affects export |
EXP |
ABCC1 protein affects the export of Fluo-3 |
CTD |
PMID:15948026 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
multiple interactions increases secretion |
ISO |
Adenosine Triphosphate promotes the reaction [ABCC2 protein results in increased secretion of Fluo-3]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased secretion of Fluo-3] |
CTD |
PMID:9794919 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
multiple interactions |
ISO |
[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein; Tranylcypromine inhibits the reaction [[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] |
CTD |
PMID:23850985 |
|
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
multiple interactions |
ISO |
[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein; Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] |
CTD |
PMID:23850985 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
decreases activity |
ISO |
Fluorescein results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
multiple interactions |
ISO |
Fluorescein inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:11602689 |
|
NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
multiple interactions increases uptake |
ISO |
bisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; bisphenol F promotes the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; Probenecid inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; tetrabromobisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] |
CTD |
PMID:27989701 |
|
NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372
|
|
G |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
increases uptake multiple interactions |
ISO |
SLCO3A1 protein results in increased uptake of Fluorescein Cyclosporine promotes the reaction [SLCO3A1 protein results in increased uptake of Fluorescein]; simvastatin acid affects the reaction [SLCO3A1 protein results in increased uptake of Fluorescein] |
CTD |
PMID:28887287 |
|
NCBI chr 7:73,925,166...74,204,528
Ensembl chr 7:73,925,167...74,204,528
|
|
|
G |
Abcb7 |
ATP-binding cassette, sub-family B member 7 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ABCB7 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:103,324,171...103,457,452
Ensembl chr X:103,324,263...103,457,462
|
|
G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
|
|
G |
Anxa4 |
annexin A4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ANXA4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
|
|
G |
Arhgap6 |
Rho GTPase activating protein 6 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ARHGAP6 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:167,578,091...168,087,436
Ensembl chr X:167,578,095...168,087,431
|
|
G |
Azi2 |
5-azacytidine induced gene 2 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to AZI2 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:117,869,510...117,898,866
Ensembl chr 9:117,869,567...117,898,862
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CAPZB protein |
CTD |
PMID:27129696 |
|
NCBI chr 4:138,920,210...139,019,131
Ensembl chr 4:138,920,210...139,019,129
|
|
G |
Cd109 |
CD109 antigen |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD109 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:78,522,828...78,623,542
Ensembl chr 9:78,522,828...78,623,535
|
|
G |
Cd180 |
CD180 antigen |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD180 protein |
CTD |
PMID:27129696 |
|
NCBI chr13:102,830,055...102,843,139
Ensembl chr13:102,830,066...102,876,137
|
|
G |
Cd86 |
CD86 antigen |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cd93 |
CD93 antigen |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD93 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:148,278,571...148,285,455
Ensembl chr 2:148,278,560...148,285,483
|
|
G |
Cdc20 |
cell division cycle 20 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CDC20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549
|
|
G |
Copa |
coatomer protein complex subunit alpha |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to COPA protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:171,909,885...171,949,899
Ensembl chr 1:171,910,096...171,949,897
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to DCAF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr12:83,567,145...83,588,768
Ensembl chr12:83,567,240...83,588,694
|
|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to DOT1L protein |
CTD |
PMID:27129696 |
|
NCBI chr10:80,590,935...80,631,295
Ensembl chr10:80,591,040...80,631,295
|
|
G |
Elac1 |
elaC ribonuclease Z 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ELAC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr18:73,868,109...73,887,589
Ensembl chr18:73,868,109...73,887,550
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ENPP7 protein |
CTD |
PMID:27129696 |
|
NCBI chr11:118,879,007...118,884,047
Ensembl chr11:118,879,014...118,884,047
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to FLRT3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:140,500,118...140,513,396
Ensembl chr 2:140,492,834...140,513,389
|
|
G |
Fn1 |
fibronectin 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to FN1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP |
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of HMOX1 protein Fluorescein-5-isothiocyanate results in increased expression of HMOX1 protein |
CTD |
PMID:27871981 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hspa5 |
heat shock protein 5 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to HSPA5 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa9 |
heat shock protein 9 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to HSPA9 protein |
CTD |
PMID:27129696 |
|
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IFNG protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein |
CTD |
PMID:29198882 PMID:36870414 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IKBKB protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IKZF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:128,466,708...128,505,668
Ensembl chr10:128,466,712...128,505,227
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
[Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL17A protein |
CTD |
PMID:36870414 |
|
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il17re |
interleukin 17 receptor E |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IL17RE protein |
CTD |
PMID:27129696 |
|
NCBI chr 6:113,435,659...113,447,719
Ensembl chr 6:113,435,445...113,447,719
|
|
G |
Il31ra |
interleukin 31 receptor A |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IL31RA protein |
CTD |
PMID:27129696 |
|
NCBI chr13:112,649,439...112,717,266
Ensembl chr13:112,656,432...112,730,894
|
|
G |
Il4 |
interleukin 4 |
multiple interactions increases expression |
EXP |
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; [dibutyrylglycerol analog co-treated with Fluorescein-5-isothiocyanate] affects the secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IL4 protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]] |
CTD |
PMID:27871981 PMID:29198882 PMID:36870414 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Lypd3 |
Ly6/Plaur domain containing 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to LYPD3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 7:24,335,995...24,340,543
Ensembl chr 7:24,335,975...24,340,543
|
|
G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr15:79,230,813...79,243,278
Ensembl chr15:79,230,821...79,243,276
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to MAP3K20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:72,115,970...72,272,954
Ensembl chr 2:72,115,981...72,272,954
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK1 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK1 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:27129696 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK3 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK8 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK8 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:27129696 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:27129696 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
|
|
G |
Mybpc1 |
myosin binding protein C, slow-type |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to MYBPC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:88,354,141...88,441,051
Ensembl chr10:88,354,141...88,441,014
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
EXP |
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein |
CTD |
PMID:27871981 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression multiple interactions |
ISO EXP |
Fluorescein-5-isothiocyanate results in increased expression of NQO1 mRNA Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]; Melatonin inhibits the reaction [diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]] |
CTD |
PMID:20491607 PMID:27871981 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PLCE1 protein |
CTD |
PMID:27129696 |
|
NCBI chr19:38,469,438...38,773,549
Ensembl chr19:38,469,557...38,773,474
|
|
G |
Postn |
periostin, osteoblast specific factor |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to POSTN protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
|
|
G |
Pprc1 |
peroxisome proliferative activated receptor, gamma, coactivator-related 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PPRC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr19:46,044,955...46,061,348
Ensembl chr19:46,033,325...46,061,354
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
|
|
G |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PSD4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:24,257,571...24,299,882
Ensembl chr 2:24,257,592...24,304,966
|
|
G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PSMD14 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:61,542,038...61,630,720
Ensembl chr 2:61,542,038...61,630,720
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
EXP |
[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein; Melatonin inhibits the reaction [[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein] |
CTD |
PMID:27871981 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SCN5A protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:119,312,470...119,408,096
Ensembl chr 9:119,312,474...119,408,082
|
|
G |
Skor1 |
SKI family transcriptional corepressor 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SKOR1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:63,045,446...63,056,243
Ensembl chr 9:63,045,452...63,056,243
|
|
G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
multiple interactions increases uptake |
ISO |
Taurocholic Acid promotes the reaction [SLC10A1 protein results in increased uptake of Fluorescein-5-isothiocyanate] |
CTD |
PMID:32209977 |
|
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
|
|
G |
Slc38a10 |
solute carrier family 38, member 10 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SLC38A10 protein |
CTD |
PMID:27129696 |
|
NCBI chr11:119,994,777...120,042,177
Ensembl chr11:119,994,786...120,042,172
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases phosphorylation multiple interactions |
EXP |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
increases phosphorylation multiple interactions |
EXP |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
multiple interactions increases phosphorylation |
EXP |
diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to TRPA1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
|
|
G |
Tslp |
thymic stromal lymphopoietin |
increases expression multiple interactions |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of TSLP protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]] |
CTD |
PMID:27871981 |
|
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Usp3 |
ubiquitin specific peptidase 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to USP3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:66,421,573...66,501,996
Ensembl chr 9:66,421,919...66,500,424
|
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]] |
CTD |
PMID:35901927 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2L1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of CAT protein] |
CTD |
PMID:35901927 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of GPX1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
multiple interactions |
ISO |
gallein inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein] |
CTD |
PMID:27160165 |
|
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
|
|
|
G |
Bax |
BCL2-associated X protein |
increases expression |
ISO |
JBIR-99 results in increased expression of BAX protein |
CTD |
PMID:31433962 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression |
ISO |
JBIR-99 results in decreased expression of BCL2 protein |
CTD |
PMID:31433962 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
JBIR-99 results in increased expression of CASP3 protein |
CTD |
PMID:31433962 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
JBIR-99 results in increased expression of CYCS protein |
CTD |
PMID:31433962 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
increases expression |
ISO |
JBIR-99 results in increased expression of IKBKB protein |
CTD |
PMID:31433962 |
|
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
decreases expression |
ISO |
JBIR-99 results in decreased expression of PARP1 protein |
CTD |
PMID:31433962 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
increases expression |
ISO |
JBIR-99 results in increased expression of RELA protein |
CTD |
PMID:31433962 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions increases expression |
ISO |
Dichlororibofuranosylbenzimidazole inhibits the reaction [mangiferin results in increased expression of ABCB1 protein] mangiferin results in increased expression of ABCB1 mRNA; mangiferin results in increased expression of ABCB1 protein |
CTD |
PMID:20513373 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
decreases expression |
ISO |
mangiferin results in decreased expression of ABL1 mRNA |
CTD |
PMID:15498116 |
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
multiple interactions increases phosphorylation |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of ACACA protein] |
CTD |
PMID:22292039 |
|
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Ache |
acetylcholinesterase |
decreases activity multiple interactions |
EXP |
mangiferin results in decreased activity of ACHE protein mangiferin inhibits the reaction [Scopolamine results in decreased expression of ACHE protein] |
CTD |
PMID:19182383 PMID:22426032 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
|
|
G |
Adrb3 |
adrenergic receptor, beta 3 |
multiple interactions |
EXP |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein |
CTD |
PMID:32417366 |
|
NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
ISO |
mangiferin results in decreased expression of AGER mRNA; mangiferin results in decreased expression of AGER protein |
CTD |
PMID:24036348 |
|
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of AIFM1 protein] |
CTD |
PMID:19201465 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:19201465 PMID:22465218 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
affects binding |
ISO |
mangiferin binds to ALB protein |
CTD |
PMID:19157745 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] |
CTD |
PMID:23451106 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of BAX protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein] |
CTD |
PMID:19201465 PMID:23451106 PMID:24095822 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] |
CTD |
PMID:21420233 PMID:22118634 PMID:23451106 PMID:24095822 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of BCL2L1 protein |
CTD |
PMID:21547680 PMID:26996543 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
mangiferin results in decreased expression of BIRC5 protein |
CTD |
PMID:26996543 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
C3 |
complement component 3 |
decreases expression |
EXP |
mangiferin results in decreased expression of C3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Calcr |
calcitonin receptor |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP3 protein] mangiferin results in increased activity of CASP3 protein mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP3 protein] |
CTD |
PMID:21547680 PMID:22118634 PMID:22310181 PMID:23451106 PMID:26996543 PMID:37455591 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of CASP8 protein mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP8 protein] |
CTD |
PMID:32420661 PMID:37455591 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP9 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] |
CTD |
PMID:22118634 PMID:23451106 PMID:37455591 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions increases activity |
EXP ISO |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CAT mRNA]; mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] mangiferin inhibits the reaction [Mercuric Chloride results in decreased expression of CAT protein] mangiferin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] mangiferin results in increased activity of CAT protein |
CTD |
PMID:15161907 PMID:16076520 PMID:16584858 PMID:16697266 PMID:17433543 PMID:18816296 PMID:19201465 PMID:20629087 PMID:23451106 PMID:27125760 PMID:29223569 More...
|
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
mangiferin results in decreased expression of CCL2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] |
CTD |
PMID:15135318 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
mangiferin results in increased expression of CCNB1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions increases expression |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased expression of CD36 protein] |
CTD |
PMID:22292039 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cdh1 |
cadherin 1 |
increases expression affects expression multiple interactions |
ISO |
mangiferin results in increased expression of CDH1 protein mangiferin affects the expression of CDH1 protein lipopolysaccharide, Escherichia coli O111 B4 affects the reaction [mangiferin affects the expression of CDH1 protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
increases expression |
ISO |
mangiferin results in increased expression of CDK1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of CHUK protein] |
CTD |
PMID:21420233 PMID:22310181 PMID:23451106 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
multiple interactions |
EXP |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA |
CTD |
PMID:32417366 |
|
NCBI chr18:67,476,634...67,500,864
Ensembl chr18:67,476,674...67,500,855
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col4a1 |
collagen, type IV, alpha 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of CPT1A protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of CPT1A protein] |
CTD |
PMID:22292039 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions decreases expression |
EXP |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] mangiferin results in decreased expression of CSF2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
multiple interactions decreases expression |
EXP |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein] mangiferin results in decreased expression of CSF3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases response to substance |
ISO |
CTNNB1 protein results in decreased susceptibility to mangiferin |
CTD |
PMID:23707762 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Ctnnd1 |
catenin delta 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form] |
CTD |
PMID:24912632 |
|
NCBI chr 2:84,417,440...84,489,321
Ensembl chr 2:84,430,415...84,481,109 Ensembl chr 2:84,430,415...84,481,109
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] |
CTD |
PMID:19172585 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions affects expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein] mangiferin affects the expression of CXCL15 protein |
CTD |
PMID:21420233 PMID:21837981 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
ISO |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CXCR4 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA] |
CTD |
PMID:21420233 PMID:32420661 |
|
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
mangiferin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity increases expression |
ISO |
mangiferin results in decreased activity of CYP1A2 protein mangiferin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:18053976 PMID:22815239 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2A6 protein |
CTD |
PMID:22815239 |
|
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2C6V1 protein |
CTD |
PMID:18053976 |
|
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2C9 protein |
CTD |
PMID:22815239 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2D6 protein |
CTD |
PMID:22815239 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2E1 protein |
CTD |
PMID:18053976 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr15:39,609,326...39,624,334
Ensembl chr15:39,609,326...39,624,334
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
decreases expression affects expression multiple interactions |
ISO |
mangiferin results in decreased expression of DGAT2 protein mangiferin affects the expression of DGAT2 mRNA; mangiferin affects the expression of DGAT2 protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of DGAT2 protein] |
CTD |
PMID:22292039 PMID:25123789 |
|
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Methylmercury Compounds results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:28071871 |
|
NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
|
|
G |
F10 |
coagulation factor X |
decreases activity |
ISO |
mangiferin analog results in decreased activity of F10 protein |
CTD |
PMID:21732671 |
|
NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
mangiferin results in increased expression of FAS protein |
CTD |
PMID:17634039 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fbp1 |
fructose bisphosphatase 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of FBP1 mRNA |
CTD |
PMID:19028559 |
|
NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Gcg |
glucagon |
multiple interactions |
ISO |
[mangiferin co-treated with Sitagliptin Phosphate] results in increased expression of GCG protein alternative form |
CTD |
PMID:22948814 |
|
NCBI chr 2:62,304,874...62,313,997
Ensembl chr 2:62,304,874...62,313,994
|
|
G |
Glo1 |
glyoxalase 1 |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of GLO1 mRNA mangiferin results in increased expression of and results in increased activity of GLO1 protein |
CTD |
PMID:24036348 |
|
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Streptozocin results in increased activity of GPT protein] |
CTD |
PMID:29223569 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] mangiferin inhibits the reaction [Methylmercury Compounds results in decreased activity of GSR protein] mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] |
CTD |
PMID:16697266 PMID:18816296 PMID:23451106 PMID:28071871 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein] |
CTD |
PMID:19172585 |
|
NCBI chr 5:130,011,278...130,031,890
Ensembl chr 5:130,017,852...130,031,890
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA]]; mangiferin inhibits the reaction [Galactosamine results in decreased expression of HMOX1 protein]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:22310181 PMID:36249937 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions decreases expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] mangiferin results in decreased expression of ICAM1 mRNA |
CTD |
PMID:15135318 PMID:15161907 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
decreases expression |
EXP |
mangiferin results in decreased expression of ICAM2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:106,268,482...106,278,948
Ensembl chr11:106,268,482...106,278,901
|
|
G |
Icam5 |
intercellular adhesion molecule 5, telencephalin |
decreases expression |
EXP |
mangiferin results in decreased expression of ICAM5 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:20,943,372...20,950,331
Ensembl chr 9:20,943,369...20,950,332
|
|
G |
Ifna1 |
interferon alpha 1 |
increases expression |
EXP |
mangiferin results in increased expression of IFNA1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
increases expression |
EXP |
mangiferin results in increased expression of IFNB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of IFNG mRNA] |
CTD |
PMID:12694877 PMID:15135318 PMID:15177302 PMID:15177305 PMID:15222974 PMID:16716910 PMID:22310181 More...
|
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:21420233 PMID:22310181 |
|
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of IL10 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il12a |
interleukin 12a |
decreases expression |
EXP |
mangiferin results in decreased expression of IL12A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
|
|
G |
Il12b |
interleukin 12b |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL12B mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL18 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
EXP |
mangiferin results in decreased expression of IL1A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL1B mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Methotrexate results in increased expression of IL1B protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein] |
CTD |
PMID:15381052 PMID:22310181 PMID:27125760 PMID:27474068 PMID:36249937 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il2rb |
interleukin 2 receptor, beta chain |
decreases expression |
EXP |
mangiferin results in decreased expression of IL2RB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr15:78,363,456...78,396,569
Ensembl chr15:78,363,456...78,379,471
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
mangiferin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [Streptozocin results in increased expression of IL6 protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [Ketamine results in increased expression of IL6 protein] mangiferin results in decreased expression of IL6 mRNA |
CTD |
PMID:15135318 PMID:21420233 PMID:22310181 PMID:23087136 PMID:27474068 PMID:32420661 PMID:37044004 More...
|
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions affects expression |
EXP ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of UCP1 protein [mangiferin co-treated with Sitagliptin Phosphate] results in increased expression of INS1 protein; mangiferin inhibits the reaction [Streptozocin results in increased expression of INS1 protein] mangiferin affects the expression of INS1 protein |
CTD |
PMID:22948814 PMID:24167738 PMID:32417366 PMID:37044004 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of IRF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions increases activity increases expression |
ISO |
MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein]; MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] |
CTD |
PMID:15975614 |
|
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
|
|
G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases phosphorylation |
ISO |
mangiferin results in decreased phosphorylation of MAP3K14 protein |
CTD |
PMID:26996543 |
|
NCBI chr11:103,110,590...103,158,227
Ensembl chr11:103,110,588...103,158,298
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases phosphorylation decreases activity affects binding multiple interactions |
EXP ISO |
mangiferin results in increased phosphorylation of MAPK1 protein mangiferin metabolite results in decreased activity of MAPK1 protein mangiferin metabolite binds to MAPK1 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk10 |
mitogen-activated protein kinase 10 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [aluminum maltolate results in increased expression of and results in increased activity of MAPK10 protein] |
CTD |
PMID:37455591 |
|
NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases activity increases phosphorylation |
EXP ISO |
mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] mangiferin metabolite results in decreased activity of MAPK3 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK3 protein] mangiferin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
EXP |
mangiferin results in decreased expression of MAPK8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
EXP |
mangiferin results in decreased expression of MAPK9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Max |
Max protein |
decreases expression |
EXP |
mangiferin results in decreased expression of MAX mRNA |
CTD |
PMID:15135318 |
|
NCBI chr12:76,984,045...77,009,123
Ensembl chr12:76,984,043...77,008,975
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
mangiferin results in decreased expression of MMP7 protein |
CTD |
PMID:23707762 |
|
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions decreases activity |
ISO EXP |
mangiferin results in decreased expression of MMP9 mRNA; mangiferin results in decreased expression of MMP9 protein mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein] mangiferin results in decreased expression of and results in decreased secretion of MMP9 protein mangiferin results in decreased activity of MMP9 protein |
CTD |
PMID:22465218 PMID:23707762 PMID:27125760 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein] |
CTD |
PMID:27125760 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA]]; mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein]; mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:22310181 PMID:36249937 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein] 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of NFKB1 mRNA]]; mangiferin inhibits the reaction [Methotrexate results in increased expression of NFKB1 mRNA] |
CTD |
PMID:15161907 PMID:36249937 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions increases expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFKBIA protein] mangiferin results in increased expression of NFKBIA protein mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein] |
CTD |
PMID:15161907 PMID:20683903 PMID:22310181 PMID:23451106 PMID:27474068 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta |
decreases expression multiple interactions |
EXP ISO |
mangiferin results in decreased expression of NFKBIB mRNA mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein] |
CTD |
PMID:15135318 PMID:21420233 |
|
NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
|
|
G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon |
decreases expression |
EXP |
mangiferin results in decreased expression of NFKBIE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:45,866,626...45,874,095
Ensembl chr17:45,866,629...45,874,095
|
|
G |
Nfkbil1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of NFKBIL1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:35,439,151...35,455,457
Ensembl chr17:35,439,151...35,454,768
|
|
G |
Ngf |
nerve growth factor |
increases secretion |
ISO |
mangiferin results in increased secretion of NGF protein |
CTD |
PMID:20303935 |
|
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of NLRP3 protein] |
CTD |
PMID:32420661 |
|
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP ISO |
mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of NOS2 mRNA]]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [Methotrexate results in increased expression of NOS2 mRNA]; mangiferin promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNFB protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:12694877 PMID:15381052 PMID:22118634 PMID:22310181 PMID:27474068 PMID:36249937 More...
|
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of NQO1 protein] |
CTD |
PMID:22310181 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Oga |
O-GlcNAcase |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of OGA protein]]; mangiferin inhibits the reaction [Methotrexate results in increased expression of OGA protein] |
CTD |
PMID:36249937 |
|
NCBI chr19:45,738,698...45,772,274
Ensembl chr19:45,738,698...45,772,276
|
|
G |
Per1 |
period circadian clock 1 |
multiple interactions affects expression |
ISO |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of PER1 protein] mangiferin affects the expression of PER1 protein |
CTD |
PMID:32420661 |
|
NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786
|
|
G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
decreases activity |
ISO |
mangiferin results in decreased activity of PLA2G2A protein |
CTD |
PMID:15177302 |
|
NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases activity |
ISO EXP |
MK-886 inhibits the reaction [mangiferin results in increased activity of PPARA protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARA mRNA |
CTD |
PMID:15975614 PMID:32417366 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein |
CTD |
PMID:29223569 PMID:32417366 PMID:36249937 PMID:37044004 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
multiple interactions |
EXP |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A protein |
CTD |
PMID:32417366 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prdm16 |
PR domain containing 16 |
multiple interactions |
EXP |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 protein |
CTD |
PMID:32417366 |
|
NCBI chr 4:154,400,579...154,721,851
Ensembl chr 4:154,400,582...154,721,330
|
|
G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
multiple interactions |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein |
CTD |
PMID:22292039 |
|
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions affects expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of PTGS2 protein] mangiferin affects the expression of PTGS2 mRNA |
CTD |
PMID:15161907 PMID:15381052 PMID:18621015 PMID:19026997 PMID:21420233 PMID:27474068 PMID:36249937 More...
|
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of RAF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions affects localization decreases expression decreases localization |
ISO EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the localization of RELA protein 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of and results in increased phosphorylation of RELA protein]]; mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [Galactosamine results in increased expression of RELA protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of and results in increased phosphorylation of RELA protein]; mangiferin inhibits the reaction [Streptozocin results in increased expression of RELA mRNA] mangiferin results in decreased expression of RELA mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein]; mangiferin inhibits the reaction [Scopolamine results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein] mangiferin results in decreased localization of RELA protein |
CTD |
PMID:15135318 PMID:15161907 PMID:19182383 PMID:19201465 PMID:20683903 PMID:21547680 PMID:22310181 PMID:23451106 PMID:26996543 PMID:27474068 PMID:36249937 PMID:37044004 More...
|
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Relb |
avian reticuloendotheliosis viral (v-rel) oncogene related B |
decreases expression |
EXP |
mangiferin results in decreased expression of RELB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363
|
|
G |
Ripk1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of RIPK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
|
|
G |
Saa1 |
serum amyloid A 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of SAA1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
|
|
G |
Sele |
selectin, endothelial cell |
decreases expression |
EXP |
mangiferin results in decreased expression of SELE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
|
|
G |
Selplg |
selectin, platelet (p-selectin) ligand |
decreases expression |
EXP |
mangiferin results in decreased expression of SELPLG mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:113,955,859...113,970,576
Ensembl chr 5:113,956,597...113,970,705
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
increases expression |
EXP |
mangiferin results in increased expression of SLC22A1 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
|
|
G |
Slc22a12 |
solute carrier family 22 (organic anion/cation transporter), member 12 |
decreases expression |
EXP |
mangiferin results in decreased expression of SLC22A12 mRNA; mangiferin results in decreased expression of SLC22A12 protein |
CTD |
PMID:21348301 |
|
NCBI chr19:6,585,884...6,593,100
Ensembl chr19:6,585,875...6,593,062
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
increases expression |
EXP |
mangiferin results in increased expression of SLC22A2 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
increases expression |
EXP |
mangiferin results in increased expression of SLC22A4 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
|
|
G |
Slc22a5 |
solute carrier family 22 (organic cation transporter), member 5 |
increases expression |
EXP |
mangiferin results in increased expression of SLC22A5 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
|
|
G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
multiple interactions increases expression |
EXP ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; mangiferin affects the localization of and results in increased activity of SLC2A4 protein; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose] mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] mangiferin results in increased expression of SLC2A4 mRNA |
CTD |
PMID:19477051 PMID:29223569 |
|
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
|
|
G |
Snai1 |
snail family zinc finger 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of SNAI1 protein |
CTD |
PMID:23707762 |
|
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
|
|
G |
Snai2 |
snail family zinc finger 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of SNAI2 protein |
CTD |
PMID:23707762 |
|
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions |
EXP |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA] |
CTD |
PMID:17433543 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases activity |
ISO |
mangiferin results in decreased activity of SRD5A2 protein |
CTD |
PMID:20823678 |
|
NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911
|
|
G |
Srf |
serum response factor |
decreases expression |
EXP |
mangiferin results in decreased expression of SRF mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:46,857,764...46,869,194
Ensembl chr17:46,859,255...46,867,101
|
|
G |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of TAB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr15:80,017,333...80,045,908
Ensembl chr15:80,017,328...80,045,908
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of TBK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:121,382,360...121,422,699
Ensembl chr10:121,382,360...121,422,692
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases activity |
ISO |
mangiferin results in decreased activity of TERT protein |
CTD |
PMID:17634039 |
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; mangiferin inhibits the reaction [Streptozocin results in increased secretion of TGFB1 protein] |
CTD |
PMID:12694877 PMID:19706694 PMID:19960420 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tlr6 |
toll-like receptor 6 |
decreases expression |
EXP |
mangiferin results in decreased expression of TLR6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
|
|
G |
Tlr7 |
toll-like receptor 7 |
decreases expression |
EXP |
mangiferin results in decreased expression of TLR7 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
|
|
G |
Tlr8 |
toll-like receptor 8 |
decreases expression |
EXP |
mangiferin results in decreased expression of TLR8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:166,024,119...166,047,325
Ensembl chr X:166,025,692...166,047,325
|
|
G |
Tlr9 |
toll-like receptor 9 |
decreases expression |
EXP |
mangiferin results in decreased expression of TLR9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression affects expression increases secretion |
ISO EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein]; mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Streptozocin results in increased expression of TNF protein] mangiferin results in decreased expression of TNF mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; mangiferin inhibits the reaction [Scopolamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the expression of TNF protein mangiferin results in increased secretion of TNF protein |
CTD |
PMID:12694877 PMID:15135318 PMID:15161907 PMID:15177305 PMID:15222974 PMID:19172585 PMID:19182383 PMID:20303935 PMID:21420233 PMID:21837981 PMID:22118634 PMID:22310181 PMID:27125760 PMID:27474068 PMID:36249937 PMID:37044004 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
decreases expression |
EXP |
mangiferin results in decreased expression of TNFRSF11A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
|
|
G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20683903 |
|
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
decreases expression |
EXP |
mangiferin results in decreased expression of TRADD mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 8:105,985,207...105,991,226
Ensembl chr 8:105,984,918...105,991,241
|
|
G |
Traf6 |
TNF receptor-associated factor 6 |
decreases expression |
EXP |
mangiferin results in decreased expression of TRAF6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein] |
CTD |
PMID:10657591 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
multiple interactions |
EXP |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of UCP1 protein |
CTD |
PMID:32417366 |
|
NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
increases expression decreases activity |
ISO |
mangiferin results in increased expression of UGT1A1 mRNA mangiferin results in decreased activity of UGT1A1 protein |
CTD |
PMID:22815239 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
increases expression |
ISO |
mangiferin results in increased expression of UGT1A9 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
|
|
G |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
decreases activity |
ISO |
mangiferin results in decreased activity of UGT2B7 protein |
CTD |
PMID:22815239 |
|
NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
|
|
G |
Umod |
uromodulin |
affects expression |
EXP |
mangiferin affects the expression of UMOD protein |
CTD |
PMID:21348301 |
|
NCBI chr 7:119,061,931...119,078,485
Ensembl chr 7:119,061,934...119,078,505
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of VCAM1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA] |
CTD |
PMID:21420233 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
mangiferin results in decreased expression of VIM protein mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of VIM protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA] mangiferin results in decreased expression of XIAP protein |
CTD |
PMID:21420233 PMID:21547680 PMID:26996543 |
|
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases expression |
ISO |
norathyriol results in increased expression of ABCB1 protein |
CTD |
PMID:20513373 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
affects binding decreases activity |
ISO EXP |
norathyriol binds to MAPK1 protein norathyriol results in decreased activity of MAPK1 protein |
CTD |
PMID:22084399 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
decreases activity |
EXP |
norathyriol results in decreased activity of MAPK3 protein |
CTD |
PMID:22084399 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
norathyriol inhibits the reaction [GW 7647 results in increased activity of PPARA protein] |
CTD |
PMID:18393431 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
multiple interactions |
ISO |
norathyriol inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARD protein] |
CTD |
PMID:18393431 |
|
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] |
CTD |
PMID:18393431 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
norswertianolin results in increased expression of GCLC mRNA; norswertianolin results in increased expression of GCLC protein |
CTD |
PMID:30800665 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
norswertianolin results in increased expression of HMOX1 mRNA; norswertianolin results in increased expression of HMOX1 protein |
CTD |
PMID:30800665 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
EXP |
Phloxine O inhibits the reaction [calcipotriol increases expression of Tslp mRNA and protein in skin of external ear and phorbol 12-myristate 13-acetate increases expression of Tslp protein in keratinocytes] |
RGD |
PMID:29310423 |
RGD:38549374 |
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
|
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Propantheline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions |
ISO |
psorospermin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] |
CTD |
PMID:7083125 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions decreases uptake increases export |
ISO |
3-methylquercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 3-methylquercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5,7-dimethoxyflavone inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5-hydroxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-methoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-oxo-hexahydroquinoline analog inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; [zosuquidar trihydrochloride results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; abemaciclib inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; baicalein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; betulin inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; biochanin A inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; biochanin A promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; CEP 33779 inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; daidzein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; flavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; formononetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Genistein promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; isovitexin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; kaempferol inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; myricetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; naringenin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; naringin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Quercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; Quercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; quercitrin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Rutin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; tangeretin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; tangeretin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; taxifolin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123] [P-glycoprotein inducer and activator TX5 results in increased activity of ABCB1 protein] which results in increased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] inhibits the reaction [P-glycoprotein inducer and activator TX5 results in increased export of Rhodamine 123] |
CTD |
PMID:25058526 PMID:27816545 PMID:30391378 PMID:31756430 PMID:33321149 PMID:34217736 PMID:34896433 More...
|
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
increases export multiple interactions |
ISO |
ABCG2 protein results in increased export of Rhodamine 123 abemaciclib inhibits the reaction [ABCG2 protein results in increased export of Rhodamine 123] |
CTD |
PMID:27816545 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO |
rhodamine 6G results in decreased activity of ACHE protein |
CTD |
PMID:33844597 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
decreases activity |
ISO |
Rose Bengal results in decreased activity of ABCB1 protein |
CTD |
PMID:20041016 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of CYP19A1 protein |
CTD |
PMID:18310892 |
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Iyd |
iodotyrosine deiodinase |
decreases activity |
ISO |
Rose Bengal results in decreased activity of IYD protein |
CTD |
PMID:24012475 |
|
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Klkb1 |
kallikrein B, plasma 1 |
multiple interactions decreases response to substance |
EXP |
7-Ala-angiotensin (1-7) inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; nimesulide inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; splitomicin inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal] |
CTD |
PMID:25339356 |
|
NCBI chr 8:45,719,725...45,747,872
Ensembl chr 8:45,719,726...45,747,896
|
|
G |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
decreases activity |
ISO |
Rose Bengal results in decreased activity of UGT1A6 protein |
CTD |
PMID:20041016 |
|
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
affects export affects transport |
ISO |
ABCC1 protein affects the export of vadimezan metabolite ABCC1 protein affects the transport of vadimezan analog |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
affects transport affects export |
ISO |
ABCC2 protein affects the transport of vadimezan analog ABCC2 protein affects the export of vadimezan metabolite |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 protein]] |
CTD |
PMID:37046119 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases oxidation |
ISO |
Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] |
CTD |
PMID:16120190 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
EXP |
vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of GPT protein]] |
CTD |
PMID:37046119 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
increases expression |
EXP |
vadimezan results in increased expression of IFNB1 mRNA |
CTD |
PMID:36958387 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
vadimezan results in increased expression of IL1A protein |
CTD |
PMID:16944150 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
vadimezan results in increased expression of IL6 protein vadimezan results in increased expression of IL6 mRNA vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 protein]] |
CTD |
PMID:16944150 PMID:36958387 PMID:37046119 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf3 |
interferon regulatory factor 3 |
increases phosphorylation |
EXP |
vadimezan results in increased phosphorylation of IRF3 protein |
CTD |
PMID:36958387 |
|
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
P2rx1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
multiple interactions |
EXP |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of RELA protein; [vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of STING1 protein; [vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of GPT protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF protein]]; vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen] |
CTD |
PMID:37046119 |
|
NCBI chr11:72,889,882...72,906,026
Ensembl chr11:72,889,929...72,906,026
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
EXP |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of RELA protein |
CTD |
PMID:37046119 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
multiple interactions |
EXP |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of STING1 protein |
CTD |
PMID:37046119 |
|
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
EXP |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein |
CTD |
PMID:37046119 |
|
NCBI chr10:121,382,360...121,422,699
Ensembl chr10:121,382,360...121,422,692
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
TNF protein affects the reaction [vadimezan affects the metabolism of Thalidomide]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF protein]] vadimezan results in increased expression of TNF mRNA vadimezan results in increased expression of TNF protein |
CTD |
PMID:15060740 PMID:16944150 PMID:36958387 PMID:37046119 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
vadimezan results in increased expression of VEGFA protein |
CTD |
PMID:16944150 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
decreases activity multiple interactions increases export increases transport |
ISO EXP |
Xanthenes results in decreased activity of ABCB1 protein closantel results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Ivermectin results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Rafoxanide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole sulfoxide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; valspodar results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes] [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes ABCB1 protein results in increased export of Xanthenes ABCB1 protein results in increased transport of Xanthenes [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes; Calcium deficiency inhibits the reaction [ABCB1 protein results in increased export of Xanthenes] |
CTD |
PMID:18686201 PMID:20041016 PMID:20513441 PMID:21436125 PMID:25862123 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
multiple interactions |
ISO |
Xanthenes binds to and results in increased activity of AHR protein |
CTD |
PMID:21431309 PMID:28186253 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
decreases activity |
ISO |
Xanthenes results in decreased activity of UGT1A6 protein |
CTD |
PMID:18686201 PMID:20041016 |
|
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
ISO |
xanthone inhibits the reaction [[Isoproterenol results in decreased activity of ACE2 protein] which results in decreased abundance of angiotensin I (1-7)]; xanthone inhibits the reaction [Isoproterenol results in decreased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 PMID:36414029 |
|
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in increased expression of ACTA2 protein] |
CTD |
PMID:36414029 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in increased expression of AGT protein] |
CTD |
PMID:36414029 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] |
CTD |
PMID:36414029 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 |
|
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in increased expression of MIR122 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
|
|
G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in decreased expression of PRKAA2 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
|
|
G |
Sirt6 |
sirtuin 6 |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr10:81,457,621...81,463,631
Ensembl chr10:81,457,619...81,463,631
|
|
G |
Tnni3 |
troponin I, cardiac 3 |
multiple interactions |
ISO |
xanthone inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] |
CTD |
PMID:36414029 |
|
NCBI chr 7:4,521,304...4,526,228
Ensembl chr 7:4,521,304...4,527,228
|
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of FOS protein] |
CTD |
PMID:21232528 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of IRAK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of JUN protein] |
CTD |
PMID:21232528 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21232528 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:21232528 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|